miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Biosystems

• Publication date

  2016-10-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1039/C6MB00576DPMID 27714074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2016

  2016cited by this paper
• HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction

  2016cited by this paper
• Long non-coding RNAs and complex diseases: from experimental results to computational models

  2016cited by this paper
• miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin

  2016cited by this paper
• MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1

  2015cited by this paper
• Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis

  2015cited by this paper
• Semi-supervised learning for potential human microRNA-disease associations inference

  2014cited by this paper
• Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer

  2013cited by this paper
• Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy

  2013cited by this paper
• Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel

  2013cited by this paper
• p53 acetylation enhances Taxol-induced apoptosis in human cancer cells

  2012cited by this paper
• miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2

  2012cited by this paper
• MicroRNA-mediated drug resistance in breast cancer

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

  2006cited by this paper
• Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment

  2006cited by this paper
• Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?

  2006cited by this paper
• Microtubule Associated Protein (MAP)-Tau: A Novel Mediator of Paclitaxel Sensitivity In Vitro and In Vivo

  2005cited by this paper
• Chemoresistance in non-small cell lung cancer.

  2005cited by this paper
• Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.

  2005cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Repeat motifs of tau bind to the insides of microtubules in the absence of taxol

  2003cited by this paper
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

  1993cited by this paper
• Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

  1992cited by this paper
• Primary structure of high molecular weight tau present in the peripheral nervous system.

  1992cited by this paper
• Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family

  1989cited by this paper
• Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

  1986cited by this paper

• Systematic Evaluation of Transfer Learning Strategies for Clinical Chemotherapy Response Prediction

  2026cites this paper
• Role of microRNAs in lung oncogenesis: Diagnostic implications, resistance mechanisms, and therapeutic strategies.

  2025cites this paper
• An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma

  2025cites this paper
• Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis.

  2024cites this paper
• Therapeutic Contribution of Tau-Binding Thiazoloflavonoid Hybrid Derivatives Against Glioblastoma Using Pharmacological Approach in 3D Spheroids

  2024cites this paper
• Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

  2023cites this paper
• Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7

  2023cites this paper
• miR-186 induces tetraploidy in arsenic exposed human keratinocytes

  2023cites this paper
• Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha

  2023cites this paper
• MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going

  2022cites this paper
• CircPIM3 regulates taxol resistance in non-small cell lung cancer via miR-338-3p/TNFAIP8 axis

  2022cites this paper
• Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma

  2022cites this paper
• Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells

  2022cites this paper
• Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

  2022cites this paper
• The identification of miRNAs that regulate ovarian maturation in Cynoglossus semilaevis

  2022cites this paper
• Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment

  2022cites this paper
• Circular RNAcirc_0076305 Promotes Cisplatin (DDP) Resistance of Non-Small Cell Lung Cancer Cells by Regulating ABCC1 Through miR-186-5p

  2021cites this paper
• Dichotomous Role of Microtubule Associated Protein Tau as a Biomarker of Response to and a Target for Increasing Efficacy of Taxane Treatment in Cancers of Epithelial Origin.

  2021cites this paper
• A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA

  2021cites this paper
• Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.

  2020cites this paper
• The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA

  2020cites this paper
• Virtual screening of MAP-Tau protein inhibitors from Semecarpus anacardium Linn. leaf extract for cancer prevention

  2020cites this paper
• MiR-186 represses progression of renal cell cancer by directly targeting CDK6

  2020cites this paper
• Long non-coding RNA SNHG6 regulates the sensitivity of prostate cancer cells to paclitaxel by sponging miR-186

  2020cites this paper
• Expression of miR-129-5p and miR-433 in the serum of breast cancer patients and their relationship with clinicopathological features

  2020cites this paper
• Systems pharmacology reveals the multi-level synergetic mechanism of action of Ginkgo biloba L. leaves for cardiomyopathy treatment.

  2020cites this paper
• Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer

  2020cites this paper
• Advances and Challenges in Understanding MicroRNA Function in Tauopathies: A Case Study of miR-132/212

  2020cites this paper
• Exploration of gastric neuroendocrine carcinoma (GNEC) specific signaling pathways involved in chemoresistance via transcriptome and in vitro analysis

  2020cites this paper
• Tau: At the Interface Between Neurodegeneration and Cancer?

  2020cites this paper
• Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer

  2020cites this paper
• Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.

  2020cites this paper
• Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma Lung Adenocarcinoma.

  2019cites this paper
• Tau regulates the microtubule-dependent migration of glioblastoma cells via the Rho-ROCK signaling pathway

  2019cites this paper
• Overexpression of MAPT-AS1 is associated with better patient survival in breast cancer.

  2019cites this paper
• miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).

  2019influential citation
• Functions and mechanisms of miR-186 in human cancer.

  2019cites this paper
• Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT

  2019cites this paper
• Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis.

  2019cites this paper
• Role of cytokines in combinatorial immunotherapeutics of non‐small cell lung cancer through systems perspective

  2019cites this paper
• The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells

  2019cites this paper
• CMAR_A_215427 7391..7404

  2019cites this paper
• Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells

  2018cites this paper
• Fe3O4 Nanoparticles in Targeted Drug/Gene Delivery Systems

  2018cites this paper
• A review of microRNAs related to the occurrence, diagnosis, and prognosis of non-small cell lung cancer

  2018cites this paper
• miR‑186 functions as a tumor suppressor in osteosarcoma cells by suppressing the malignant phenotype and aerobic glycolysis.

  2018cites this paper
• MiR-129-5p influences the sensitivity of breast cancer MCF-7 cells to paclitaxel by regulating HMGB1

  2018cites this paper
• miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

  2017cites this paper
• Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.

  2017cites this paper
• MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1

  2017cites this paper